The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
The role of Fas ligand in immune privilege
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Self-citationDhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., & Bhardwaj, N. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.233 · Cited by 1,359
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis
Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R., & Galluzzo, A. (1997) · Science · doi:10.1126/science.275.5302.960 · Cited by 582
The Role of Fas in Autoimmune Diabetes
Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A., & Matis, L. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80178-6 · Cited by 496
Kang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450
TGF-β Released by Apoptotic T Cells Contributes to an Immunosuppressive Milieu
Chen, W., Frank, M. E., Jin, W., & Wahl, S. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00147-9 · Cited by 418
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?
Saas, P., Walker, P. R., Hahne, M., Quiquerez, A. L., Schnuriger, V, Perrin, G., French, L., Van Meir, E. G., de Tribolet, N., Tschopp, J., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119273 · Cited by 398
Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)
Chen, J.-J., Sun, Y., & Nabel, G. J. (1998) · Science · doi:10.1126/science.282.5394.1714 · Cited by 383
CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance
Griffith, T. S., Yu, X., Herndon, J. M., Green, D. R., & Ferguson, T. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80305-2 · Cited by 382
Self-citationCaspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand
Miwa, K., Asano, M., Horai, R., Iwakura, Y., Nagata, S., & Suda, T. (1998) · Nature Medicine · doi:10.1038/3276 · Cited by 373
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367
Self-citationAllison, J., Georgiou, H. M., Strasser, A., & Vaux, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3943 · Cited by 366
Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape
Restifo, N. P. (2000) · Nature Medicine · doi:10.1038/74955 · Cited by 251
Fas Ligand: A Sensor for DNA Damage Critical in Skin Cancer Etiology
Hill, L. L., Ouhtit, A., Loughlin, S. M., Kripke, M. L., Ananthaswamy, H. N., & Owen-Schaub, L. B. (1999) · Science · doi:10.1126/science.285.5429.898 · Cited by 245
Abreu-Martin, M. T., Vidrich, A., Lynch, D. H., & Targan, S. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4147 · Cited by 241
The Fas counterattack: Cancer as a site of immune privilege
O’Connell, J., Bennett, M. W., O’Sullivan, G. C., Collins, J. K., & Shanahan, F. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01382-6 · Cited by 232
Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis
Gao, Y., Herndon, J. M., Zhang, H., Griffith, T. S., & Ferguson, T. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.887 · Cited by 217
Self-citationFas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis
Waldner, H., Sobel, R. A., Howard, E., & Kuchroo, V. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3100 · Cited by 199
Soluble Fas Ligand Is Chemotactic for Human Neutrophilic Polymorphonuclear Leukocytes
Ottonello, L., Tortolina, G., Amelotti, M., & Dallegri, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3601 · Cited by 179
Atkinson, J. P., Frank, M. M., & Austen, K. F. (2001) · Medical Entomology and Zoology · Cited by 168
Immune privilege or inflammation? Insights into the Fas ligand enigma
O’Connell, J., Houston, A. M., Bennett, M., O’Sullivan, G. C., & Shanahan, F. (2001) · Nature Medicine · doi:10.1038/85395 · Cited by 154
Sabelko, K. A., Kelly, K. A., Nahm, M. H., Cross, A. H., & Russell, J. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3096 · Cited by 150
Stassi, G., Liberto, D. D., Todaro, M., Zeuner, A., Ricci‐Vitiani, L., Stoppacciaro, A., Ruco, L. P., Farina, F., Zummo, G., & Maria, R. D. (2000) · Nature Immunology · doi:10.1038/82725 · Cited by 149
Bonfoco, E., Stuart, P. M., Brunner, T., Lin, T., Griffith, T. S., Gao, Y., Nakajima, H., Henkart, P. A., Ferguson, T. A., & Green, D. R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80668-8 · Cited by 147
Self-citationTesticular FasL is expressed by sperm cells
D’Alessio, A., Anna Riccioli, A., Lauretti, P., Padula, F., Muciaccia, B., Cesaris, P. D., Filippini, A., Nagata, S., & Elio Ziparo, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051566098 · Cited by 143
ROLE OF FAS-FAS LIGAND INTERACTIONS IN THE IMMUNOREJECTION OF ALLOGENEIC MOUSE CORNEAL TRANSPLANTS1
Yamagami, S., Kawashima, H., Tsuru, T., Yamagami, H., Kayagaki, N., Yagita∥, H., Okumura, K., & Gregerson, D. S. (1997) · Transplantation · doi:10.1097/00007890-199710270-00004 · Cited by 142
Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo
Mogil, R. J., Radvanyi, L. G., González‐Quintial, R., Miller, R. G., Mills, G. B., Theofilopoulos, A. N., & Green, D. R. (1995) · International Immunology · doi:10.1093/intimm/7.9.1451 · Cited by 136
Self-citationSabelko-Downes, K. A., Cross, A. H., & Russell, J. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1195 · Cited by 134
Induction of Specific T Cell Tolerance by Fas Ligand- Expressing Antigen-Presenting Cells
Zhang, H., Su, X., Liu, D., Liu, W., Yang, P., Wang, Z., Edwards, C. K., Bluethmann, H., Mountz, J. D., & Zhou, T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1423 · Cited by 126
Lin, T., Brunner, T., Tietz, B., Madsen, J., Bonfoco, E., Reaves, M., Huflejt, M. E., & Green, D. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci896 · Cited by 121
Self-citationFas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
Suvannavejh, G. C., Canto, M. C. D., Matis, L. A., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8561 · Cited by 121
Gutierrez-Steil, C., Wrone-Smith, T., Sun, X., Krueger, J. G., Coven, T. R., & Nickoloff, B. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1165 · Cited by 110
Human retinal pigment epithelial cell-induced apoptosis in activated T cells.
Jørgensen, A. K., Wiencke, A. K., la Cour, M., Kæstel, C. G., Madsen, H. O., Hamann, S., Lui, G. M., Scherfig, E., Prause, J. U., Svejgaard, A., et al. (1998) · PubMed · Cited by 106
FAS LIGAND GENE TRANSFER TO RENAL ALLOGRAFTS IN RATS: Effects on Allograft Survival1,2
Swenson, K., Ke, B., Wang, T., Markowitz, J. S., Maggard, M. A., Spear, G. S., Imagawa, D. K., Goss, J. A., Busuttil, R. W., & Seu, P. (1998) · Transplantation · doi:10.1097/00007890-199801270-00002 · Cited by 103
Accelerated rejection of Fas ligand-expressing heart grafts.
Takeuchi, T., Ueki, T., Nishimatsu, H., Kajiwara, T., Ishida, T., Jishage, K., Ueda, O., Suzuki, H., Li, B.-X., Moriyama, N., et al. (1999) · Journal of Immunology · doi:10.4049/jimmunol.162.1.518 · Cited by 102
Bissonnette, R. P., Brunner, T., Lazarchik, S. B., Yoo, N. J., Boehm, M. F., Green, D. R., & Heyman, R. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5576 · Cited by 101
Self-citationFrancavilla, S., D'Abrizio, P., Rucci, N., Silvano, G., Properzi, G., Straface, E., Cordeschi, G., Necozione, S., Gnessi, L., Arizzi, M., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2692 · Cited by 101
Shudo, K., Ryu, I., & Shigekazu, N. (2003) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 89
Technical Note: Aberrant Detection of Cell Surface Fas Ligand with Anti-Peptide Antibodies
Smith, D. G., Sieg, S. F., & Kaplan, D. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4159 · Cited by 84
Inhibition of the alloantibody response by CD95 ligand
Arai, H., Chanz, S. Y., Bishop, D. K., & Nabel, G. J. (1997) · Nature Medicine · doi:10.1038/nm0897-843 · Cited by 81
Hill, L. L., Shreedhar, V. K., Kripke, M. L., & Owen-Schaub, L. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1285 · Cited by 75
Fas Ligand (CD95L) Protects Neurons Against Perforin- Mediated T Lymphocyte Cytotoxicity
Medana, I. M., Li, Z., Flügel, A., Tschopp, J., Wekerle, H., & Neumann, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.674 · Cited by 71
CD95 ligand in graft rejection
Yagita∥, H., Seino, K., Kayagaki, N., & Okumura, K. (1996) · Nature · doi:10.1038/379682a0 · Cited by 69
Regulation of Fas Ligand-Induced Apoptosis by TNF
Elzey, B. D., Griffith, T. S., Herndon, J. M., Barreiro, R., Tschopp, J., & Ferguson, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3049 · Cited by 66
Self-citationPROLONGED SURVIVAL OF RAT LIVER ALLOGRAFTS TRANSFECTED WITH FAS LIGAND-EXPRESSING PLASMID1
Li, X., Okuyama, T., Tamura, A., Enosawa, S., Kaneda, Y., Takahara, S., Funashima, N., Yamada, M., Amemiya, H., & Suzuki, S. (1998) · Transplantation · doi:10.1097/00007890-199812150-00003 · Cited by 66
Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
Hori, J., Joyce, N. C., & Streilein, J. W. (2000) · PubMed · Cited by 64
Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation
Gochuico, B. R., Miranda, K., Hessel, E. M., Bie, J. J. D., van Oosterhout, A. J. M., Cruikshank, W. W., & Fine, A. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.274.3.l444 · Cited by 55
Sata, M., Luo, Z., & Walsh, K. X. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6964 · Cited by 51
Transgenic Expression of Fas Ligand on Thyroid Follicular Cells Prevents Autoimmune Thyroiditis
Batteux, F., Lorès, P., Bucchini, D., & Chiocchia, G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1681 · Cited by 48
CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies
Sträter, J., Walczak, H., Hasel, C., Melzner, I., Leithäuser, F., & Mӧller, P. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400813 · Cited by 48
A NON-CLEAVABLE MUTANT OF FAS LIGAND DOES NOT PREVENT NEUTROPHILIC DESTRUCTION OF ISLET TRANSPLANTS1
Kang, S., Braat, D., Schneider, D. B., O’Rourke, R. W., Lin, Z., Ascher, N. L., Dichek, D. A., Bækkeskov, S., & Stock, P. G. (2000) · Transplantation · doi:10.1097/00007890-200005150-00014 · Cited by 39
Ke, B., Coito, A. J., Kato, H., Zhai, Y., Wang, T., Sawitzki, B., Seu, P., Busuttil, R. W., & Kupiec-Weglinski, J. W. (2000) · Transplantation · doi:10.1097/00007890-200004270-00027 · Cited by 36
Tourneur, L., Malassagne, B., Batteux, F., Fabrè, M., Mistou, S., Lallemand, E., Lorès, P., & Chiocchia, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1338 · Cited by 34
Khar, A., Varalakshmi, C., Pardhasaradhi, B. V. V., Ali, A., & Kumari, A. L. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1367 · Cited by 31
Kawashima, H., Yamagami, S., Tsuru, T., & Gregerson, D. S. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271005 · Cited by 28
MURINE XENOGENEIC IMMUNE RESPONSES TO THE HUMAN TESTIS: A PRESUMED IMMUNE-PRIVILEGED TISSUE1
Kimmel, S. G., Ohbatake, M., Kushida, M. M., Merguerian, P. A., Clarke, I. D., & Kim, P. C. W. (2000) · Transplantation · doi:10.1097/00007890-200003270-00010 · Cited by 24
Saitoh, A., Kawanabe, T., He, W., Kawamura, T., Shimada, S., Kayagaki, N., Yagita∥, H., & Okumura, K. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00062.x · Cited by 19
Deng, C., Goluszko, E., & Christadoss, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3458 · Cited by 15
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
Osteoblast-Osteoclast Communication and Bone Homeostasis
Kim, J.-M., Lin, C., Stavre, Z., Greenblatt, M. B., & Shim, J.-H. (2020) · Cells · doi:10.3390/cells9092073 · Cited by 1,178
Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 961
Passegué, E., Jamieson, C. H. M., Ailles, L. E., & Weissman, I. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034201100 · Cited by 686
Metadata
- Authors
- Green, D. R., & Ferguson, T. A.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2001-12
- Volume
- 2
- Issue
- 12
- Pages
- 917-924
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2080333440
- Cited by
- 284
- References
- 61
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.